Sheldon L. Koenig - Mar 18, 2025 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Mar 18, 2025
Transactions value $
-$19,623
Form type
4
Date filed
3/19/2025, 04:02 PM
Previous filing
Mar 17, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$19.6K -13K -0.82% $1.50 1.57M Mar 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.